William Hood & Company is a differentiated industry-focused Investment Banking practice covering the Consumer, Food and Retail sectors with a specialization in Health and Wellness and Emerging Consumer Trends. William Hood & Company was founded by well-known Consumer, Food and Retail banker William Hood after a 22-year career building highly successful practices for established firms. Our team successfully marries traditional transaction experience with brand building and operational expertise that is highly valued by our clients. William Hood & Company leverages deep industry knowledge, significant experience and a powerful global network to partner with its clients to deliver customized service and drive long term success. Our transaction experience includes the following: announced sale of OLLY to Unilever, sale of GNC's Nutra Division to IVC, sale of Campbell's Habit subsidiary to Viome, sale of Atrium Innovations (Garden of Life) to Nestle ($2.3 billion), sale of the Nature's Bounty Company to KKR, sale of Holland & Barrett to Letter1 Retail ($2.4 billion), sale of Unipharm to Takeda, sale of Iovate to Xiwang Foods ($730 million), sale of Perrigo's VMS Business to IVC, Purchase of Foodstate by Pharmavite (Otsuka), sale of Healthy Directions to Helen of Tory, sale of Jamieson Laboratories to CCMP Capital ($300 million), sale of Santa Cruz Nutritionals to RoundTable Healthcare Partners, sale of Schiff Nutrition to Reckitt Benckiser ($1.4 billion), sale of Parfums de Coeur to Yellow Wood Partners, sale of Avid Health to Church & Dwight ($650 million), purchase of Airborne by Schiff Nutrition ($150 million), sale of Emergen-C to Pfizer, sale of Ganeden Biotech to Schiff Nutrition. William Hood and Company principals are recognized as thought leaders and have an extensive global network including in Europe and in Asia with a specialization in China. William Hood & Company, LLC is a U.S. registered broker-dealer and member of FINRA and SIPC.